| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1,025.26 Million | USD 2,404.99 Million | 8.90% | 2024 |
FrequentlyAsked Questions
Gastrointestinal (GI) stool testing is a medical diagnostic procedure conducted to look for viruses, bacteria, or parasites in the GI system of a patient.
The global GI stool testing market is expected to be driven by the rising prevalence of gastrointestinal medical disorders.
According to study, the global GI stool testing market size was worth around USD 1,025.26 million in 2024 and is predicted to grow to around USD 2,404.99 million by 2034.
The CAGR value of the GI stool testing market is expected to be around 8.90% during 2025-2034.
The global GI stool testing market is expected to be led by North America during the forecast period.
The global GI stool testing market is led by players like GI-MAP (Diagnostic Solutions Laboratory), Genova Diagnostics, Quest Diagnostics, Eurofins Scientific, Thorne HealthTech, Atlas Biomed, Onegevity Health, BioReference Laboratories, Doctor's Data, Inc., DayTwo, Labcorp, uBiome, Everlywell, Invivo Healthcare, and Viome.
The report explores crucial aspects of the GI stool testing market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients